New Data Show Rates of US HIV/AIDS Diagnoses Are Steady; Racial Disparities Persist

New Data Show Rates of US HIV/AIDS Diagnoses Are Steady; Racial Disparities Persist

ArticlePress release
Health & Wellness
Diseases & Conditions
Contributed byLester Fahrner, MDMar 18, 2020

New Data Show Rates of US HIV/AIDS Diagnoses Are Steady; Racial Disparities Persist

HIV testing rates are higher among CDC-recommended groups

than general population

Rates of HIV/AIDS diagnoses in the United States stayed steady for the years 2000-2003, but sharp racial disparities remain, according to an analysis of data from 32 states, the Centers for Disease Control and Prevention announced today.

Rates of HIV/AIDS diagnosis—the number of new diagnoses of HIV per 100,000 population regardless of whether infection has progressed to AIDS—among non-Hispanic African-Americans in the United States were significantly higher than among other racial and ethnic groups. The rate of HIV/AIDS diagnosis among African-American females in 2003 (53 cases per 100,000 population) was more than 18 times higher than among white women and almost five times higher than among Latina women. In addition, African-American women accounted for 69 percent of female HIV diagnoses during 2000-2003.

“The number of women of color in the United States that continue to be affected by this devastating disease is quite sobering,” said Secretary of Health and Human Services Tommy G. Thompson. ”We will not become complacent in our efforts to aggressively fight this disease which continues to rob too many people of the quality of life they deserve.”

Overall, 125,800 people were diagnosed with HIV/AIDS in the 32 states that conducted confidential, name-based reporting from 2000 through 2003. More than half of diagnoses (51 percent) were among African Americans, although they account for only 13 percent of the population of the 32 states. Thirty-two percent of diagnoses were among whites and 15 percent were among Latinos. Asians/Pacific Islanders and American Indians each accounted for 1 percent of diagnoses during the 4-year period.

Men of color were also disproportionately represented among rates of new HIV diagnoses. In 2003, the highest rate of HIV/AIDS diagnosis was among African-American males (103.4 per 100,000 population), a rate almost seven times that of white men and nearly three times the rate among Latino men. Men who have sex with men (MSM) continued to account for the largest proportion of diagnoses—44 percent of all HIV diagnoses during the four-year period, and 61 percent of diagnoses among men.

“Nearly a quarter of a century has passed since HIV/AIDS was first recognized and it’s simply unacceptable that so many people continue to be infected by this virus,” said CDC Director Dr. Julie Gerberding. “We are making progress in our fight but many challenges lie ahead.”

New Data on HIV Testing Trends Released

CDC today also issued new data on HIV testing trends in the U.S. from two national surveys conducted in 2002 with more than 100,000 people. The National Health Interview Survey (NHIS) showed that 10 percent of adults reported HIV testing in the previous year. The Behavioral Risk Factor Surveillance System (BRFSS) reported that about 12 percent of adults were tested in the previous 12 months. The overall proportion of Americans who report being tested during the prior year has remained roughly stable since 1992.

“Our efforts are paying off. People who should be getting tested are coming forward and learning their status,’’ said Dr. Gerberding. “It’s important that people know their status because modern medical care and treatments are helping people who are infected with HIV live healthy and productive lives.”

Greater use of the rapid HIV tests approved in 2002 is expected to continue to increase the number of persons who get tested. The tests can provide preliminary results in less than a half-hour and can be used outside of clinical settings, making it possible to reach people at risk in a wide variety of settings. To date, CDC has:

Purchased and distributed 500,000 rapid test kits to local health departments and community-based organizations

Started pilot projects in seven cities to use the rapid tests in non-clinical settings, and

Trained more than 1,000 people to perform the rapid test and to provide counseling and testing

Testing rates were higher among groups for whom HIV testing is recommended by CDC than among the general population. Nearly one-fourth of people at increased behavioral risk for HIV were tested in the previous year – 21 percent in the NHIS and 27 percent in the BRFSS. About half of pregnant women – 48 percent in NHIS and 54 percent in BRFSS – reported being tested in the previous year.

Increased access to voluntary counseling and testing is an essential part of reducing new HIV infections in the U.S. CDC estimates that between 850,000 and 950,000 Americans are now living with HIV, and that one-fourth are unaware of their infection. An estimated 40,000 new HIV infections continue to occur in the U.S. each year.

CDC currently funds prevention programs for African-American and Latina women that emphasize better links between prevention and treatment services, education about how to best protect against HIV transmission, and effective programs for reducing risky behaviors. CDC also provides funds to 104 community-based organizations for HIV/AIDS prevention. More than 15% of these programs focus on girls and women; 84% serve African-American girls and women and 72% serve Hispanic girls and women.

The 32 states included in the analysis have conducted confidential, name-based HIV/AIDS case reporting for at least four years . These states represented 49% of the nation’s AIDS cases during the 2000-2003 period. The data may not be nationally representative since California, New York, and several other states with high numbers of AIDS cases were not included. However, national AIDS statistics suggest the racial and ethnic disparities seen in this analysis are occurring nationwide.

In 2003, to help reduce barriers to early HIV diagnosis, CDC launched Advancing HIV Prevention (AHP), an initiative designed to increase knowledge of HIV status among at-risk and infected individuals. AHP is one component of CDC’s work with communities, public health partners, and health care providers across the nation to help at-risk individuals reduce their risk, to help HIV-infected individuals take steps to protect their own health and avoid infecting others, to develop new behavioral and biomedical approaches to prevent infection, and to diagnose and treat STDs, which can increase the risk of HIV transmission.

The reports on HIV/AIDS diagnoses and HIV testing are available at www.cdc.gov/mmwr. For more information about World AIDS Day 2004, visit: http://www.omhrc.gov/hivaidsobservances/.

Was this article helpful

On the Article

Lester Fahrner, MD picture
Approved by

Lester Fahrner, MD

Chief Medical Officer, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!